Safety and effectiveness of Omnitrope(®) (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data

There are known geographical differences in growth hormone deficiency (GHD) patient populations and treatment practices. Here, we present a comparison of safety and effectiveness data from patients treated with recombinant human growth hormone (rhGH) in the USA versus other countries. PAtients TReat...

Descripción completa

Detalles Bibliográficos
Autores principales: Backeljauw, Philippe, Kanumakala, Shankar, Loche, Sandro, Schwab, Karl Otfried, Miller, Bradley S., Levy, Richard, McCormick, Kenneth, Zouater, Hichem, Zabransky, Markus, Campbell, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110540/
https://www.ncbi.nlm.nih.gov/pubmed/35275291
http://dx.doi.org/10.1007/s00431-022-04409-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110540/
https://www.ncbi.nlm.nih.gov/pubmed/35275291
http://dx.doi.org/10.1007/s00431-022-04409-8

Ejemplares similares